Oversold, OCGN is gaining momentum. According to Tip Ranks, “Ocugen has inked a deal with India-based Bharat Biotech for the US rights for the company’s vaccine COVAXIN. And Bharat has now reported positive second interim analysis results from the COVAXIN Phase 3 trials. The vaccine displayed an overall efficacy rate of 78%, with 100% success against severe cases of the disease. COVAXIN...
Continue reading >>The stock market was mixed on Wednesday after Treasury Secretary Janet Yellen attempted to walk back her comments where she said interest rates may need to rise to keep the economy from overheating. Yellen clarified that she was not making a forecast or advocating for a rate hike from the Fed.The blue-chips rebounded to set a fresh record high while Tech and the small-caps showed continued...
Continue reading >>...
Continue reading >>The stock market was mixed on Wednesday after Treasury Secretary Janet Yellen attempted to walk back her comments where she said interest rates may need to rise to keep the economy from overheating. Yellen clarified that she was not making a forecast or advocating for a rate hike from the Fed.The blue-chips rebounded to set a fresh record high while Tech and the small-caps showed continued...
Continue reading >>...
Continue reading >>The stock market showed continued weakness on Tuesday with all of the major indexes down for the session as inflation fears remained a key concern. However, the Nasdaq’s recovery from an intraday 2% pullback into positive territory was a slight silver-lining.It remains to been seen if the recovery off the lows was a temporary head fake but we will find out quickly with Wednesday’s update on...
Continue reading >>